VCRE (Vicore Pharma Holding AB) Interest Income: $3.98 Mil (TTM As of Mar. 2026)

What is Vicore Pharma Holding AB Interest Income?

Vicore Pharma Holding AB VCRE -7.54% 13 Interest Income is $3.98 Mil as of Mar. 2026. GuruFocus rates VCRE with a GF Score™ of 13/100. The stock has 5 warning signs investors should review.

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Vicore Pharma Holding AB's interest income for the three months ended in Mar. 2026 was $1.71 Mil. Its interest income for the trailing twelve months (TTM) ended in Mar. 2026 was $3.98 Mil.

Vicore Pharma Holding AB Interest Income Historical Data

* Premium members only.

The historical data trend for Vicore Pharma Holding AB's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vicore Pharma Holding AB Interest Income Chart

Vicore Pharma Holding AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Income

Get a 7-Day Free Trial

0.07

0.09

1.03

1.92

2.57

Vicore Pharma Holding AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Income	Get a 7-Day Free Trial															0.63	1.08	0.64	0.55	1.71

13GF Score

Vicore Pharma Holding AB VCRE

Interest Income is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Vicore Pharma Holding AB Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.98 Mil.

Frequently Asked Questions Learn more about Interest Income →

What does a Interest Income of $3.98 Mil mean?

Vicore Pharma Holding AB (VCRE) has a Interest Income of $3.98 Mil as of Mar. 2026. Interest Income is the amount a company receives on savings accounts and certificates of deposits. View historical data on Vicore Pharma Holding AB and its competitors.

Is Vicore Pharma Holding AB's Interest Income too high?

Vicore Pharma Holding AB's current Interest Income is $3.98 Mil. Overall, Vicore Pharma Holding AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.

How does Vicore Pharma Holding AB's Interest Income compare to ?

Vicore Pharma Holding AB's Interest Income of $3.98 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Income for a Biotechnology company?

A good Interest Income depends on the Biotechnology industry context. However, Interest Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Income mean?

A high Interest Income can signal that a stock is expensive relative to its fundamentals. Interest Income is the amount a company receives on savings accounts and certificates of deposits. View historical data on Vicore Pharma Holding AB and its competitors. Vicore Pharma Holding AB's current Interest Income is $3.98 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vicore Pharma Holding AB stock overvalued right now?

Vicore Pharma Holding AB (VCRE) has a current Interest Income of $3.98 Mil. The current Interest Income is $3.98 Mil. Vicore Pharma Holding AB's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Income calculated?

Interest Income is calculated from a company's financial statements. For Vicore Pharma Holding AB (VCRE), the current Interest Income is $3.98 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vicore Pharma Holding AB Business Description

Industry Healthcare Biotechnology

Comparable Companies

Other Exchanges VICO:Sweden 6Y4:Germany

Address Kornhamnstorg 53, Stockholm, SWE, 111 27

Website https://www.vicorepharma.com

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.

13GF Score

Get the complete analysis for VCRE

Interest Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.03

Price

View VCRE Analysis

See Interest Income data for all stocks →